Baillie Gifford & CO Summit Therapeutics Inc. Transaction History

Baillie Gifford & CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.92 - $2.38 $401,591 - $1.04 Million	-436,512 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$5.15 - $8.46 $330,892 - $543,563	64,251 Added 17.26%	436,512 $3.26 Million
Q3 2020 Nov 12, 2020	BUY	$3.08 - $3.8 $1.15 Million - $1.41 Million	372,261 New	372,261 $1.28 Million

107

41.3M

103K

29.9K

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $1.46B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.